Figure 5.
Figure 5. 15d-PGJ2 down-regulates the expression of cellular inhibitor-of-apoptosis proteins (cIAPs) and cFLIP. (A) HS-Sultan cells were treated with 10 μM 15d-PGJ2,10 μM dexamethasone (DexaM), or control diluent for 8 hours. Whole-cell lysates were assayed for NF-κB DNA-binding activity by EMSA (top panel) or immunoblotted with the indicated antibodies (lower panels). Inhibition of NF-κB by 15d-PGJ2 is associated with a decrease in the expression of cIAP-1, cIAP-2, cFLIP, and XIAP. (B) Time-course modulation of IAP protein expression in HS-Sultan cells treated with 15d-PGJ2 (10 μM) or control diluent. At the indicated times, the levels of cIAP-1, cIAP-2, XIAP, cFLIP, and Bcl-XL were determined by Western blot analysis. cIAP-1 and cIAP-2 bands are indicated by arrows.

15d-PGJ2down-regulates the expression of cellular inhibitor-of-apoptosis proteins (cIAPs) and cFLIP. (A) HS-Sultan cells were treated with 10 μM 15d-PGJ2,10 μM dexamethasone (DexaM), or control diluent for 8 hours. Whole-cell lysates were assayed for NF-κB DNA-binding activity by EMSA (top panel) or immunoblotted with the indicated antibodies (lower panels). Inhibition of NF-κB by 15d-PGJ2 is associated with a decrease in the expression of cIAP-1, cIAP-2, cFLIP, and XIAP. (B) Time-course modulation of IAP protein expression in HS-Sultan cells treated with 15d-PGJ2 (10 μM) or control diluent. At the indicated times, the levels of cIAP-1, cIAP-2, XIAP, cFLIP, and Bcl-XL were determined by Western blot analysis. cIAP-1 and cIAP-2 bands are indicated by arrows.

Close Modal

or Create an Account

Close Modal
Close Modal